Rehmann Capital Advisory Group

Position in NBIX — Neurocrine Biosciences Inc

CIK 1633037 LANSING, MI

Position in NBIX

as of Jun 30, 2026 · filed Aug 20, 2026 Compact

Position Value

$1,425,848

New position

Shares Held

8,460

first reported quarter

Ownership

0.008%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#356

of 772 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Rehmann Capital Advisory Group holds $3,034,859 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (47.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	8,460	$1,425,848
2	UTHR	UNITED THERAPEUTICS Corp	2,213	$1,199,069
3	HLN	Haleon plc	33,176	$309,532
4	BCRX	Biocryst Pharmaceuticals Inc	10,041	$100,410

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,425,848	8,460	—	Shares	Sole	2026-08-20
No filing history on record for this holder in this stock.